These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 4040728)

  • 41. Lysozyme activity and immunoglobulins in middle ear effusion fluid in acute purulent otitis media and in otitis media with effusion.
    Virtanen S; Lahikainen EA
    Scand J Infect Dis; 1979; 11(1):63-7. PubMed ID: 419370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydrolytic enzymes in otitis media pathogenesis.
    Diven WF; Doyle WJ; Vietmeier B
    Ann Otol Rhinol Laryngol Suppl; 1988; 132():6-9. PubMed ID: 2837976
    [No Abstract]   [Full Text] [Related]  

  • 43. Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion.
    Närkiö-Mäkelä M; Teppo AM; Meri S
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1745-9. PubMed ID: 11037838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Granulocyte protease inhibition in acute and chronic middle ear effusion.
    Carlsson B; Lundberg C; Ohlsson K
    Acta Otolaryngol; 1983; 95(3-4):341-9. PubMed ID: 6188318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Chlamydia trachomatis with polymerase chain reaction in middle ear fluid in otitis media with effusion.
    Keles E; Bulut Y; Kaygusuz I; Karlidag T; Yalçin S; Ozdarendeli A; Alpay HC
    Indian Pediatr; 2005 Jul; 42(7):686-91. PubMed ID: 16085970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming growth factor-beta expression in otitis media with effusion.
    Cooter MS; Eisma RJ; Burleson JA; Leonard G; Lafreniere D; Kreutzer DL
    Laryngoscope; 1998 Jul; 108(7):1066-70. PubMed ID: 9665258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of vascular endothelial growth factor in pediatric otitis media with effusion.
    Sekiyama K; Ohori J; Matsune S; Kurono Y
    Auris Nasus Larynx; 2011 Jun; 38(3):319-24. PubMed ID: 21227609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alteration of adenoid tissue alkaline and acid phosphatase in children with secretory otitis media.
    Jesic S; Stojiljkovic L; Petrovic Z; Djordjevic V; Nesic V; Stosic S
    Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1069-76. PubMed ID: 16406075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of pneumococcal polysaccharide vaccine (Prevnar) on middle ear fluid in children undergoing tympanostomy tube insertion.
    Caspary H; Welch JC; Lawson L; Darrow D; Buescher S; Shahab S; Derkay CS
    Laryngoscope; 2004 Jun; 114(6):975-80. PubMed ID: 15179198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytokines in experimental otitis media with effusion.
    Johnson MD; Fitzgerald JE; Leonard G; Burleson JA; Kreutzer DL
    Laryngoscope; 1994 Feb; 104(2):191-6. PubMed ID: 8302123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endotoxin and tumor necrosis factor-alpha in middle ear effusions in relation to upper airway infection.
    Nell MJ; Grote JJ
    Laryngoscope; 1999 Nov; 109(11):1815-9. PubMed ID: 10569413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endotoxin in middle-ear effusions from patients with chronic otitis media with effusion.
    DeMaria TF; Prior RB; Briggs BR; Lim DJ; Birck HG
    J Clin Microbiol; 1984 Jul; 20(1):15-7. PubMed ID: 6611350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antifibrinolytic activity in middle ear effusion.
    Hamaguchi Y; Sakakura Y; Ukai K; Ohi M; Miyoshi Y
    ORL J Otorhinolaryngol Relat Spec; 1984; 46(5):235-41. PubMed ID: 6237294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endotoxin in middle ear effusions: in cases with persistent effusion after acute otitis media.
    Iino Y; Yuasa R; Kaneko Y; Takasaka T; Kawamoto K
    Auris Nasus Larynx; 1985; 12 Suppl 1():S94-6. PubMed ID: 3835949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical study of protease inhibitors in experimental otitis media with effusion.
    Juhn SK; Hamaguchi Y
    Ann Otol Rhinol Laryngol Suppl; 1988; 132():10-3. PubMed ID: 2454602
    [No Abstract]   [Full Text] [Related]  

  • 56. Kinetics of lysosomal protease activity in human otitis media with effusion.
    Hamaguchi Y; Sakakura Y; Majima Y; Juhn SK
    Am J Otolaryngol; 1987; 8(4):194-8. PubMed ID: 2443031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A study of concentration of ampicillin into middle ear effusion after administration of bacampicillin].
    Itabashi T; Kawamura S; Sugita R; Fujimaki Y; Deguchi K; Fukayama S; Yokota N; Tanaka S; Nishimura Y; Yoshihara H
    Jpn J Antibiot; 1986 Aug; 39(8):1975-80. PubMed ID: 3795476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of superoxide dismutase in otitis media with effusion.
    Shigemi H; Egashira T; Kurono Y; Mogi G
    Ann Otol Rhinol Laryngol; 1998 Apr; 107(4):327-31. PubMed ID: 9557768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunologic characteristics of cytokines in otitis media with effusion.
    Himi T; Suzuki T; Kodama H; Takezawa H; Kataura A
    Ann Otol Rhinol Laryngol Suppl; 1992 Oct; 157():21-5. PubMed ID: 1416648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leukocyte esterase activity in effusion fluid of patients with otitis media.
    Lebovics RS; Murthy VV; Karmen A
    Otolaryngol Head Neck Surg; 1993 Mar; 108(3):248-50. PubMed ID: 8464637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.